TNF and inflammatory bowel disease: Anti-tumor necrosis factor-alpha (TNF-α) medication is a significant breakthrough in IBD treatment, perhaps facilitating mucosal repair by mitigating elevated inflammation-related intestinal epithelial cell (IEC) death (21).